Visfatin levels in Behcet's disease

Area of Science:

• Immunology
• Endocrinology
• Rheumatology

Background:

• Behcet's disease is a multisystem inflammatory disorder of unknown etiology.
• Visfatin, an adipokine, plays a role in inflammatory processes.
• Altered adipokine levels are implicated in various autoimmune diseases.

Purpose of the Study:

• To determine serum visfatin levels in patients with Behcet's disease.
• To investigate the correlation between visfatin levels and disease activity in Behcet's disease.
• To compare visfatin levels between active, inactive Behcet's disease patients, and healthy controls.

Main Methods:

• Serum samples were collected from 58 Behcet's disease patients (19 inactive, 39 active) and 30 healthy controls.
• Visfatin and tumor necrosis factor alpha (TNF-α) levels were quantified using the ELISA method.
• Statistical analysis was performed to compare groups and assess correlations.

Main Results:

• Serum visfatin levels were significantly lower in both active and inactive Behcet's disease patients compared to the healthy control group (p < 0.05).
• No significant difference in visfatin levels was observed between the active and inactive Behcet's disease patient groups.
• Tumor necrosis factor alpha (TNF-α) levels were also measured, suggesting a potential role in visfatin regulation.

Conclusions:

• Serum visfatin levels are decreased in patients with Behcet's disease, irrespective of disease activity.
• Pro-inflammatory cytokines like TNF-α may suppress visfatin gene expression in Behcet's disease.
• Further research is warranted to elucidate the precise role of visfatin in the pathogenesis of Behcet's disease.